Company Filing History:
Years Active: 1986-1989
Title: Gregory L Swartz: Innovator in Antibiotic Development
Introduction
Gregory L Swartz is a notable inventor based in Midland, MI (US). He has made significant contributions to the field of antibiotic development, holding 2 patents that showcase his innovative work. His research focuses on novel microorganisms and their applications in promoting animal health.
Latest Patents
Swartz's latest patents include Antibiotic A26201-1 and Antibiotic A26201-2. These antibiotics are produced by the novel microorganism, Actinoplanes species A26201 (ATCC 39573), under aqueous aerobic fermentation conditions. They are particularly useful for inhibiting gram-positive bacteria and promoting the growth of both monogastric and ruminant animals.
Career Highlights
Gregory L Swartz is associated with The Dow Chemical Company, where he has been able to leverage his expertise in microbiology and fermentation technology. His work has contributed to advancements in antibiotic production and animal health.
Collaborations
Some of his notable coworkers include Joseph W Whalen and Lisa J Rheaume, who have collaborated with him on various projects related to antibiotic development.
Conclusion
Gregory L Swartz's innovative work in antibiotic development highlights the importance of research in improving animal health and combating bacterial infections. His contributions continue to impact the field positively.